When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer ...

SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

Tumor necrosis factor ligand superfamily member 9 (4-1BBL), also known as 4-1BB ligand, CD137L, or TNFSF9, is a cytokine that binds to TNFRSF9. It serves as the high-affinity ligand for 4-1BB and ...

A researcher has proposed a more targeted approach to AI drug discovery, which includes a rigorous evaluation protocol.

Affinity chromatography has emerged as an indispensable tool in modern protein purification, leveraging highly selective interactions between target proteins and immobilised ligands. This technique, ...

AlphaFold 3 (AF3), the latest AI model from Google DeepMind and Isomorphic Labs, can predict the structures and interactions of nearly all biomolecules with unprecedented accuracy, opening new avenues ...

A study presented at the annual European Society of Medical Oncology Congress 2025 and published in the journal Annals of ...

Investing.com -- SciSparc Ltd. (NASDAQ:SPRC) stock rose 2.6% on Thursday after the clinical-stage pharmaceutical company announced plans to launch a new initiative focused on 3D protein modeling using ...

Unlike existing treatments that block individual cytokines such as IL-4, IL-13 or IL-31, therapies targeting the OX40 pathway ...

The global (MMS) market is poised for remarkable expansion, projected to rise from USD 201.0 million in 2025 to an impressive ...